Combined anti-cholinergic and short-acting β-agonist therapy reduces hospital admissions for acute asthma

Journal of Paediatrics and Child Health

Volumn 50, Issue 7, 2014, Pages 577-578

  Barrett, Michael Joseph ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE; SHORT ACTING DRUG; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ASTHMA; CHILDHOOD DISEASE; DISEASE SEVERITY; EMERGENCY WARD; HOSPITAL ADMISSION; HUMAN; MONOTHERAPY; NEBULIZER; NOTE; PRIORITY JOURNAL; RISK;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ASTHMA; CHOLINERGIC ANTAGONISTS; HUMANS;

EID: 84903935589     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12669     Document Type: Note

References (2)

1. 2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst. Rev. 2013; (8): Art. No.: CD000060, doi: 10.1002/14651858.CD000060.pub2.
2. Griffiths B, Ducharme FM,. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Paediatr. Respir. Rev. 2013; 14: 234-235. Epub 2013/09/28.